FGFR4 Gly388Arg polymorphism and prognosis of breast and colorectal cancer

  • Authors:
    • Monica Spinola
    • Vera Piera Leoni
    • Jun-ichi Tanuma
    • Angela Pettinicchio
    • Milo Frattini
    • Stefano Signoroni
    • Roberto Agresti
    • Riccardo Giovanazzi
    • Silvana Pilotti
    • Lucio Bertario
    • Fernando Ravagnani
    • Tommaso A. Dragani
  • View Affiliations

  • Published online on: August 1, 2005     https://doi.org/10.3892/or.14.2.415
  • Pages: 415-419
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

A functional Gly388Arg variation in the FGFR4 gene has been reported to be associated with breast and colorectal cancer prognostic parameters. To further examine the functional role of this genetic polymorphism at the population level, we assessed the presence of the Arg388 allele in 142 breast carcinoma patients, 179 colorectal carcinoma patients and 220 general population controls with respect to an association with cancer prognosis and/or risk. No significant association with cancer risk, survival or any other prognostic parameters was observed in either breast or colorectal cancer. A pooled analysis of the present and published data on nodal status by FGFR4 genotypes revealed no association in either breast cancer [odds ratio (OR), 1.0; 95% confidence interval (CI), 0.7-1.4; 702 subjects] or colorectal cancer (OR, 1.4; 95% CI, 0.6-3.4; 260 cases). Thus, the FGFR4 polymorphism may not be relevant in predicting nodal involvement of breast cancer or colon cancer patients.

Related Articles

Journal Cover

August 2005
Volume 14 Issue 2

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Spinola M, Leoni VP, Tanuma J, Pettinicchio A, Frattini M, Signoroni S, Agresti R, Giovanazzi R, Pilotti S, Bertario L, Bertario L, et al: FGFR4 Gly388Arg polymorphism and prognosis of breast and colorectal cancer. Oncol Rep 14: 415-419, 2005
APA
Spinola, M., Leoni, V.P., Tanuma, J., Pettinicchio, A., Frattini, M., Signoroni, S. ... Dragani, T.A. (2005). FGFR4 Gly388Arg polymorphism and prognosis of breast and colorectal cancer. Oncology Reports, 14, 415-419. https://doi.org/10.3892/or.14.2.415
MLA
Spinola, M., Leoni, V. P., Tanuma, J., Pettinicchio, A., Frattini, M., Signoroni, S., Agresti, R., Giovanazzi, R., Pilotti, S., Bertario, L., Ravagnani, F., Dragani, T. A."FGFR4 Gly388Arg polymorphism and prognosis of breast and colorectal cancer". Oncology Reports 14.2 (2005): 415-419.
Chicago
Spinola, M., Leoni, V. P., Tanuma, J., Pettinicchio, A., Frattini, M., Signoroni, S., Agresti, R., Giovanazzi, R., Pilotti, S., Bertario, L., Ravagnani, F., Dragani, T. A."FGFR4 Gly388Arg polymorphism and prognosis of breast and colorectal cancer". Oncology Reports 14, no. 2 (2005): 415-419. https://doi.org/10.3892/or.14.2.415